C. Chemaslé

A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma

L. Kavalieris, P.J. O’Sullivan, James M. Suttie et al. · BMC Urology · 2015 · 46 citations · Full text

Medicine, Oncology, Urology +17

An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer

Madhusudan P. Koya, Sue Osborne, C. Chemaslé et al. · BMC Urology · 2020 · 31 citations · Full text

Medicine, Oncology, Urology +13

[Repair of female urinary incontinence with prolene "TVT": preliminary results of a multicenter and prospective survey].

M. Soulié, F Delbert-Julhes, X Cuvillier et al. · PubMed · 2000 · 17 citations

Medicine, Surgery, Urology +14

Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician–Patient Real-World Clinical Data Analysis

Tony Lough, Qingyang Luo, P.J. O’Sullivan et al. · Oncology and Therapy · 2018 · 10 citations · Full text

Medicine, Urology, Cancer Screening +15